( LSE:SNG, Bloomberg:SNG@LN, RICS:SYNG.L )

News from Synairgen plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.


Mar 10, 2017, 02:00 ET Synairgen plc: Additional Positive Data in Lung Fibrosis

- Phase I clinical trial scheduled to start in H2 2017 Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, today...

May 24, 2006, 01:00 ET Synairgen plc: New Research Signals Second Indication for Interferon Beta Programme in COPD

SOUTHAMPTON, England, May 24 /PRNewswire/ -- Synairgen, the drug discovery company focused on the underlying causes of asthma and chronic...